Connor, Clark & Lunn Investment Management »

Pacira Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 81k 15.05
2023-06-30 $1.1M 28k 40.07
2023-03-31 $1.7M 42k 40.81
2022-12-31 $618k 16k 38.61
2022-03-31 $502k 6.6k 76.36
2021-12-31 $511k 8.5k 60.22
2014-03-31 $417k 5.4k 77.22